Back
HFA Premium Access

Use of sacubitril valsartan in heart failure due to post-chemotherapy symptomatic ventricular dysfunction

Session: Poster Session 4 - Chronic Heart Failure – Pathophysiology and Mechanisms
Topic: Cardiotoxicity of Drugs and Other Therapies
Speaker: Doctor V. Gregorietti (Buenos Aires, AR)
Event: Heart Failure 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Vanesa Gregorietti

Institute of Oncology Angel H. Roffo, Buenos Aires (Argentina)
0 follower

25 more presentations in this session

Safety and tolerability of a first in class chymase inhibitor in clinically stable patients with left-ventricular dysfunction after myocardial infarction

Speaker: Doctor M. Senni (Bergamo, IT)

Access
Abstract
Like
Thumbnail

The relations between pro- and anti-inflammatory cytokines contractile ability of the myocardium in patients with coronary artery disease

Access
Like
Thumbnail

Predictors of galectin-3 in patients with heart failure and reduced ejection fraction

Speaker: Doctor I. Alexanian (Athens, GR)

Access
Abstract
Like
Thumbnail

The role of Response-to-Diuretic in predicting prognosis in discharged heart failure patients after an acute decompensation.

Speaker: Doctor M. Feola (Mondovi, IT)

Access
Abstract
Like
Thumbnail

Mobile cardiopaging in toxic cardiomyopathy diagnostics in cancer patients

Speaker: Professor N. Lyamina (Moscow, RU)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 4 - Chronic Heart Failure – Pathophysiology and Mechanisms

Speakers: Doctor V. Gregorietti, Doctor M. Senni, Doctor I. Alexanian, Doctor M. Feola, Professor N. Lyamina
Access
Like
Thumbnail

About the event

Image

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources